US Stock MarketDetailed Quotes
ATNFW 180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM)
- 0.0090
- -0.0005-5.26%
Close Oct 11 16:00 ET
0.0094High0.0090Low
0.0094High0.0090Low4.57KVolume0.0094Open0.0095Pre Close44.00Turnover0.00%Turnover Ratio--P/E (Static)0Shares0.030052wk High--P/B0Float Cap0.003052wk Low--Dividend TTM0Shs Float2.9700Historical High--Div YieldTTM4.21%Amplitude0.0030Historical Low0.0090Avg Price1Lot Size
About 180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM) Company
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Company Profile
SymbolATNFW
Company Name180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM)
Listing DateJun 27, 2017
Founded2016
CEOMr. Blair Jordan
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address3000 El Camino Real,Building 4,Suite 200
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94306
Phone1-650-507-0669
Company Executives
- Name
- Position
- Salary
- Blair Jordan
- Interim Chief Executive Officer and Director
- --
- Omar Jimenez
- Chief Financial Officer
- --
- Professor Lawrence J. Steinman, M.D.
- Director
- 253.52K
- Ryan L. Smith
- Independent Director
- --